Expression of ornithine decarboxylase mRNA in gastric carcinoma

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1634-1638

  Mori, Masaki ^a   Honda, Masayuki ^a   Shibuta, Kenji ^a   Baba, Kinya ^a   Nakashima, Hideaki ^a   Haraguchi, Masaru ^a   Koba, Fumio ^b   Ueo, Hiroaki ^b   Sugimachi, Keizo ^a   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

Author keywords

c myc; gastric cancer; ornithine decarboxylase; polymerase chain reaction; reverse transcription

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ORNITHINE DECARBOXYLASE;

CANCER INVASION; CONFERENCE PAPER; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C MYC; POLYAMINE METABOLISM; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR GROWTH;

BASE SEQUENCE; FEMALE; GASTRIC MUCOSA; GENES, MYC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ORNITHINE DECARBOXYLASE; POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 13344284631     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1634::AID-CNCR32>3.0.CO;2-Z     Document Type: Conference Paper

References (23)

1. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-74.
2. Shantz LM, Pegg AE. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 1994;54: 2313-6.
3. Auvinen M, Paasinen A, Andersson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992;360:355-8.
4. Okuzumi J, Yamane T, Kitao Y, Tokiwa K, Yamaguchi T, Fujita Y, et al. Increased mucosal ornithine decarboxylase activity in human gastric cancer. Cancer Res 1991;51:1448-51.
5. Berdinskikh NK, Ignatenko NA, Zaletok SP, Ganina KP, Chorniy VA. Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int J Cancer 1991;47:496-8.
6. Yoshida M, Hayashi H, Taira M, Isono K. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer. Cancer Res 1992;52:6671-5.
7. Clifford M, Morgan D, Yuspa SH, Soler AP, Gilmour S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 1995;55:1680-6.
8. Hietala OA, Yum KY, Pilon J, O'Donnell K, Holroyde CP, Kline I, et al. Properties of ornithine decarboxylase in human colorectal adenocarcinomas. Cancer Res 1990;50:2088-94.
9. Westin T, Edstrom S, Lundholm K, Gustafsson B. Evaluation of ornithine decarboxylase activity as a marker for tumor growth rate in malignant tumors. Am J Surg 1991;162:288-93.
10. Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-myc. Proc Natl Acad Sci USA 1993;90:7804-8.
11. Evan GI, Wylie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-28.
12. Eilers M, Schirm S, Bishop JM. The Myc protein activates transcription of the α-prothymosin gene. EMBO J 1991;10: 133-41.
13. Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD Jr, Chen LB. Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 1993;8: 2821-6.
14. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr, Chen LB. Significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 1993;105:820-6.
15. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by the reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-20.
16. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981;11:127-39.
17. Mori M, Sakaguchi H, Akazawa K, Tsuneyoshi M, Sueishi K, Sugimachi K. Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol 1995;26:504-8.
18. Terashima S, Teranishi Y, Hoshino Y, Ogata M, Ito F, Konno A, et al. Ornithine decarboxylase activity in stomach cancer [in Japanese with English abstract]. Jpn J Cancer Clin 1994;40:847-50.
19. Nakanishi I, Sowa M, Kato Y, Chung Y, Otani S. Heterogeneity of ornithine decarboxylase activity in gastric cancer tissue [in Japanese with English abstract]. Oncologia 1993;26:697-701.
20. Kubota S, Yamada T, Kamei S, Seyama Y. Ornithine decarboxylase is directly involved in mouse mammary carcinoma cell invasion in vitro. Biochem Biophys Res Commun 1995;208:1106-15.
21. Hoshino Y, Teranishi Y, Terashima S, Ogata M, Itoh F, Konno A, et al. Ornithine decarboxylase activity in gastric cancer. [in Japanese with English abstract]. J Jpn Res Soc Gastroenterol Carcinogenesis 1993;5:329-32.
22. Thomas T, Thomas TJ. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implication. Breast Cancer Res Treat 1994;29:89-201.
23. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1992;6:1915-22.